Editorially reviewed by Dr Fatimah Khan, registered with the Pakistan Medical and Dental Council (PMDC no. 104595-P). Editorial medical reviewer; does not prescribe or review patient assessments.
Review details
Review recorded:
Review scope: This article edition.
Editorial reviewer for Prescrivia. Editorial review does not establish participation in patient consultations.
Clinical review does not replace individual medical advice. Prescrivia is a technology intermediary; independent doctors make clinical decisions.
Legal review: Qualified review pending.
Language review: Qualified review pending.
Source and review
Source published:
Attributed source update:
Text edited:
Editorial role: Editorial team. This description does not establish an individual credential or clinical review of this edition.
Read our editorial policy and corrections. Edit dates and source descriptions do not establish qualified review.
What is azithromycin used for?
Azithromycin is a macrolide antibiotic used for selected bacterial infections, including some chest, skin and sexually transmitted infections. The NHS medicine guide describes tablets, capsules, oral liquid and hospital injection forms. Eye-drop products have a separate use.
The infection and formulation matter. An antibiotic course for one condition cannot be copied to treat another, and a short course is not evidence that an infection has been correctly diagnosed.
Its role in chlamydia treatment
The CDC's 2021 chlamydia guidance recommends doxycycline for most adolescents and adults and lists azithromycin as an alternative in specified circumstances. Pregnancy has separate recommendations. The guidance discusses lower efficacy concerns for azithromycin in rectal infection.
This US guidance is a dated reference, not a universal European prescription. A clinician should use the applicable local guidance, infection site, pregnancy status and ability to complete treatment. This article does not provide competing azithromycin regimens for readers to select themselves.
Testing and follow-up help distinguish chlamydia from other causes of symptoms. Treatment for Mycoplasma genitalium or gonorrhoea follows different guidance; the word “STI” does not make antibiotics interchangeable.
Partners and follow-up
For chlamydia, CDC recommends avoiding sex until the relevant treatment period is complete and partners have been treated. It recommends retesting approximately three months later; pregnancy and other situations can require additional testing. Ask the treating clinician for the instructions that apply to your diagnosis.
Do not share antibiotics or use leftover tablets. Symptoms improving does not establish that partner management or follow-up is complete.
Formulation and safety questions
Follow the leaflet for the exact tablet, capsule or liquid. Food instructions can differ between presentations; a generic “with or without food” rule is insufficient.
The NHS suitability guidance highlights allergy, irregular heart rhythms, liver or kidney conditions, previous antibiotic-associated diarrhoea and myasthenia gravis. Tell the prescriber about all medicines, including non-prescription products. Nausea and diarrhoea are possible side effects; persistent or concerning symptoms need medical advice.
Before treatment, ask what infection is being treated, why this antibiotic was chosen, and which partner and testing steps remain.
Prescrivia's role
Read how online assessment works. Prescrivia is a technology intermediary. Independent doctors make clinical decisions and licensed pharmacies dispense where appropriate. Assessment does not guarantee an antibiotic, access or outcome.
General information only, not medical advice. Follow the leaflet for your actual product and discuss decisions with a qualified clinician. See the current clinical, legal and language review statuses for this edition.
Sources
- NHS UK guidance: bacterial indications, formulations, food instructions and common effects.
- NHS precautions involving allergy, heart rhythm, liver/kidney conditions and myasthenia gravis.
- US 2021 chlamydia guidance: doxycycline recommendation, azithromycin alternative, pregnancy differences and follow-up.
Sources checked online on 6 October 2026. UK and US guidance is identified as such; it does not establish availability or prescribing rules across all European countries.